Compounding slides :(

5.0(1)
studied byStudied by 1 person
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
Card Sorting

1/121

encourage image

There's no tags or description

Looks like no tags are added yet.

Study Analytics
Name
Mastery
Learn
Test
Matching
Spaced

No study sessions yet.

122 Terms

1
New cards

what is compounding?

creation of a pharmaceutical preparation (drug) by a licensed pharmacist to meet the unique needs of an individual patient when a commercially available drug does not meet those needs

2
New cards

what is nonsterile compounding?

combining, admixing, diluting, pooling, reconstituting other than as provided in the manufacturer’s labeling, or otherwise altering a drug product or bulk drug substance to create a nonsterile preparation

3
New cards

which USP is nonsterile?

795

4
New cards

Examples of nonsterile compounds

capsules or powders, oral liquid medications (suspensions, solutions), topical medications (ointments, lotions, gels, medication sticks), rectal medications, otic medications (ear drops)

5
New cards

what is sterile compounding

combining, admixing, diluting, pooling, reconstituting, repackaging, or otherwise altering a drug product or bulk drug substance to create a sterile medication

6
New cards

which USP is for sterile compounding

797

7
New cards

why do we need sterile medications?

when route of medication administration bypasses the body’s natural defense mechanisms

8
New cards

examples of sterile compounds

IV medications, fluids and nutrition; epidural, intrathecal medications, ophthalmic medications (eye drops, eye ointments), inhaled medications.

9
New cards

why do we compound?

drug or dosage form is not commercially available, dose unavailable, or formulation is inappropriate for patient.

10
New cards

T/F: it is legal to compound a preparation because it is cheaper than the commercially available product

FALSE

11
New cards

what are some risks with compounding

compounded drugs are not FDA-approved and therefore do not have the same safety, quality, and effectiveness requirements as FDA-approved drugs; increased risk when compounders engage in large-scale, non-patient specific compounding and distribution

12
New cards

which compounding center had a fungal meningitis outbreak due to contaminated methylprednisolone epidurals

New England Compounding Center (NECC)

13
New cards

what did the 2012 fungal meningitis outbreak lead to compounding wise?

new legal safeguards, Drug Quality and Security Act (2013) amended the Federal Food, Drug, and Cosmetic Act (FD&C). 503A and 503B of the FD&C address human drug compounding and prevents compounding pharmacies from functioning like drug manufacturers.

14
New cards

what is 503A

addresses the conditions in which a licensed pharmacist may compound a drug product in a state licensed pharmacy or a federal facility (compounded drug is for an identified patient; drugs are distributed pursuant to a valid patient-specific prescription; drugs compounded in advance of receiving prescriptions are only in limited quantities; must keep batching record)

15
New cards

T/F: 503A pharmacies are exempt from current good manufacturing practices (CGMP)

TRUE

16
New cards

rules for outpatient (community) 503A pharmacies?

patient receives a prescription for the compounded product

17
New cards

rules for inpatient (healthcare facility) 503A pharmacies?

order is placed in the patient’s health record/chart for the compounded drug product

18
New cards

what is 503B

established a new, voluntary category of compounders known as outsourcing facilities; may distribute compounded drugs pursuant to a patient-specific prescription OR in response to an order from a healthcare provider such as a hospital, that is not for an identified individual patient (e.g. for office stock).

19
New cards

T/F: 503B outsourcing pharmacies are subject to CGMP requirements

True

20
New cards

how are 503B outsourcing facilities different from 503A pharmacies?

compounding for long-term inventory and sale; elect to register with the FDA as an outsourcing facility; subject to different laws, inspections, and industrial regulations (CGMP); beyond the scope of typical hospital or community practice.

21
New cards

what is a preparation?

a compounded drug dosage form to which a compounder has introduced a drug (Ex: aspirin powder paper prepared in your pharmacy from tablets)

22
New cards

what is a product?

a manufactured pharmaceutical dosage form (ex: aspirin from Bayer)

23
New cards

Errors in pharmacy compounding:

lack of knowledge of accepted standards, inadequate training, disregard of published guidelines for environmental controls or compounding procedures, mathematical errors in calculating amounts of ingredient, weighing/measuring errors, improper ingredient selection, compounding procedural errors.

24
New cards

how to be accurate in compounding

practice techniques (quiet, focused environment; calculations-write down steps with units, independent colleague checks; weighing/measuring-self “triple-check,” colleague verification; awareness of unusual quantities), drug information skills

25
New cards

safety in compounding

adherence to federal and state rules and regulations; adherence to applicable USP chapters

26
New cards

powder definition

mixtures of dry finely divided drugs and/or chemicals that may be intended for internal or external use; solid dosage form that may be comprised of only the active drug or a mixture of the active drug and other ingredients

27
New cards

nonsterile preparations where the final dosage form is a powder

bulk powders and divided powers

28
New cards

nonsterile preparations made with powders, but the final dosage form is not a powder

capsules, suspensions, solutions, ointments

29
New cards

Sources of powders for nonsterile preparations

bulk powders, crushed tablets, opened capsules

30
New cards

T/F: the weight of powder does not always equal the weight of the active pharmaceutical ingredient (API)

true

31
New cards

what is a certificate of analysis

document produced by manufacturers with results of laboratory testing verifying the product conforms to requirements (USP); required by USP for all APIs used in compounding; when compounding with powders must review assay (potency) and take this into consideration when calculating

32
New cards

T/F: when compounding you can ignore the water content in powders because it is usually negliglible

False (often, but not always, negligible)

33
New cards

compounded powders for dispensing

divided powders and bulk powders

34
New cards

what are divided powders

powder papers/chartulae/charts; single doses of powdered API individually wrapped in paper/cellophane/foil packets; more accurate dosages than bulk powders; patient-specific label should indicate quantity of active ingredients contained in one dose

35
New cards

what are bulk powders

medications are not potent and can be dosed accurately and safely using general measuring devices (teaspoon, cup); labeled for concentration of active ingredients contained in the product (%w/w, mg of drug per gram of product, etc.)

36
New cards

Advantages of powder dosage forms

tailored doses; easily administered to patients who cannot swallow tablets or capsules; drugs most stable in solid form; undesirable taste less noticeable in powder form; rapid onset (disintegration not required); external or internal use

37
New cards

if particle sizes are not uniform in powders what can happen?

the powder will segregate according to the different particle sizes which can lead to inaccurate dosing

38
New cards

importantance of uniform particle size

results in uniform dissolution rate, uniform sedimentation rate, and minimizes stratification when powders are stored/transported

39
New cards

what does comminution mean

the process of reducing the particle size of a powder

40
New cards

ways to reduce the particle size of a powder

trituration, pulverization by intervention, and levigation

41
New cards

what is trituration

mix thoroughly, make homogenous; continuous rubbing or grinding of powder in a mortar with a pestle; use for hard, fracturable powders

42
New cards

what is pulverization by intervention

uses an intervening solvent (alcohol, acetone) to dissolve the powder, then the dissolved powder is mixed in a mortar or spread on an ointment slab to enhance the evaporation of the solvent; The solvent evaporates, and the powder will recrystallize out of solution as fine particles. Used with hard crystalline powders that do not dissolve easily.

43
New cards

what is levigation

reduces particle size by triturating in a mortar or spatulating on an ointment slab with a small amount of liquid solvent in which the solid is not soluble (usually mineral oil or glycerin- the levigating agent or wetting agent); often used when compounding powders into ointments or suspensions

44
New cards

goal of blending powders

create a homogenous mixture!

45
New cards

how can blending of powders be accomplished?

homogenizers, ointment mills, grinders

46
New cards

what is geometric dilution

used when blending two or more ingredients of different quantities; method of mixing ingredients to ensure that ingredients are evenly distributed; smaller volume ingredient (active drug) is mixed with an equal volume of the other ingredient (diluent); that mixture is then mixed with an equal volume of the larger ingredient; repeated until the mixture is complete

47
New cards

what are glass mortars good for?

best used for liquids and for compounds that are oily or can stain

48
New cards

what are wedgewood mortars for?

rough surface for grinding dry crystalline and hard powders

49
New cards

what are porcelain mortars for?

the smooth surface is preferred for blending powders and pulverizing gummy consistencies

50
New cards

safety PPE when compounding nonsterile preparations

gloves must be worn, gown, hair covers, shoe coves, and face masks should be worn

51
New cards

safety precautions for powders

containment ventilated enclosure (CVE) aka powder containment hoods; protect the compounder from airborne particles; not required compounding facility to determine if/when used; consider when powder poses a respiratory or allergenic risk; this is different than the considerations for compounding with hazardous drugs (USP 800)

52
New cards

beyond use date for other nonaqueous dosage forms

180 days

53
New cards

storage temperatures for other nonaqueous dosage forms

refrigerated or room temperature

54
New cards

what is USP

A nonprofit scientific organization founded in 1820. A standard-setting organization NOT a regulatory or enforcement agency! Published the USP Compounding Compendium

55
New cards

USP 795

“Pharmaceutical compounding-nonsterile preparations", standards for compounding nonsterile medications to ensure patient benefit and reduce risks such as contamination, infection, or incorrect dosing. Not a “guideline,” must follow entire standard to be compliant

56
New cards

nonsterile compounding is:

combining, diluting, pooling, or other methods of mixing products and components; also includes reconstituting products other than the way specifically listed in the manufacturer’s labeling (also includes compounding kits)

57
New cards

Nonsterile compounding is not:

prepackaging items, splitting tablets, reconstituting according to manufacturer’s labeling

58
New cards

what is a designated person

the person responsible for overseeing all aspects of compounding at a facility - does not need to be a pharmacist

59
New cards

compounding documentation:

documentation enables a compounder to systemically trace, evaluate, and replicate the steps included throughout the preparation process of a compounded preparation; must comply with state boards of pharmacy

60
New cards

what compounding documentation is needed?

master formulation record and compounding record; should also have standard operating procedures (SOPs)

61
New cards

what is the master formulation record

the recipe for the CNSP - REQUIRED FOR ALL COMPOUNDS

62
New cards

what needs to be included in a master formulation record (MFR)

name, strength or activity, dosage form; container-closure system; complete instructions for preparing the CNSP, including equipment, supplies, and a description of the compounding steps; physical description of the final CNSP; assigned BUD and storage requirements (with reference), calculations as needed to determine and verify quantities of components and strength of API; labeling requirements; quality control procedures; other information needed to describe the process and ensure repeatability.

63
New cards

what is a compounding record

a record of ingredients used to make a CNSP; required for all compounds; the MFR and the CR can be separate or combined documents

64
New cards

what must the compounding record contain

name, strength or activity, and dosage form of the CNSP; master formulation record reference for the CNSP; calculations performed to determine and verify quantities and/or concentrations of components if appropriate; name, vender or manufacturer, lot number, and expiration date of each component; weight or measurement of each component; date and time of preparation; assigned internal lot number; total quantity compounded; physical description of the final CNSP; assigned BUD and storage requirements; results of quality control procedures; and method to identify the individuals involved in the compounding process and verifying the final CNSP

65
New cards

what is are BUDs

the date/time after which a compounded nonsterile preparation (CNSP) may not be stored or transported

66
New cards

BUD for Non preserved aqueous dosage forms

14 days

67
New cards

BUD for preserved aqueous dosage forms

35 days

68
New cards

BUD for oral nonaqueous liquids

90 days

69
New cards

storage for nonpreserved aqueous dosage forms

refrigerated

70
New cards

storage for preserved aqueous dosage forms

refrigerated or room temperature

71
New cards

storage for oral nonaqueous liquids

refrigerated or room temperature

72
New cards

what MUST the label contain

assigned internal lot number, active components (amount/activity/concentration), dosage form, amount/volume in the container, storage temp if not room temperature, and BUD

73
New cards

what should a label include but it’s not required

name/address/contact info of compounding pharmacy if CNSP will be sent outside the facility where it was compounded, route of administration, indication, special handling, and warning statements

74
New cards

what are capsules

solid oral dosage forms, unit doses of drugs enclosed within soluble shells of gelatin, may be clear or colored, and can be filled with dry powder, liquids, or gels.

75
New cards

advantages of capsules

can mask unpleasant taste/smell//appearance of API, uncompressed powders dissolve and absorb more quickly (than tablets), variety of administration routes (oral, inhalation, rectal), can be formulated to delay drug release, may be easier to swallow than tablets

76
New cards

disadvantages of capsules

can be tampered with, humidity/moisture concerns (aqueous liquids dissolve moisture shell, cannot use with hygroscopic/deliquescent materials)

77
New cards

how many capsule sizes for human use?

eight sizes

78
New cards

T/F: as capsule size number increase, the capsule size/content capacity decreases

True

79
New cards

how to select capsule size

trial and error; rule of 7s

80
New cards

how to find capsule size via rule of 7s

convert capsule content to grains, subtract grains from “7,” round to the nearest whole number, try this capsule size

81
New cards

what is the optimum capsule size

#2 or #3

82
New cards

most often used method to fill capsules

"punch” method

83
New cards

quality control for capsules

polish capsules as needed to remove fingerprints or excess powders; visually inspect for uniformity in appearance/color, uniform fill, and that it is tightly closed and locked.

84
New cards

capsule storage

dispense in plastic or glass vials; if stored in high humidity capsules will absorb moisture, become malformed or misshapen; if stored in low humidity capsules can become dry, brittle, and crack

85
New cards

examples of primary literature

clinical research studies and reports (ex: original research published in scientific refereed journal articles)

86
New cards

examples of secondary literature

summarizes and synthesizes primary literature (ex: books, literature review articles)

87
New cards

examples of tertiary literature

summaries or condensed versions of materials with references to primary or secondary sources (ex: textbook, handbook, database)

88
New cards

what information are we looking for when doing nonsterile compounding

compounding formulas, solubility/compatibility, standards; federal/state laws

89
New cards

where do we look for information regarding nonsterile compounding

databases, websites, journals, texts, and unpublished data

90
New cards

which option is an easy first step to locate a compounding formula or find out if it is commercially available

databases

91
New cards

what information do websites give us for compounding

general compounding support - contain original material as well as links to other websites; evidence-based compounding formulas (most appear in tertiary references); regulatory standards (federal and state laws)

92
New cards

what information do we get from journals

primary literature publications of evidence-based compounding formulas as well as other articles (reviews, etc.) relevant to pharmacy compounding topics

93
New cards

what information do we get from texts

less frequently used but may use for solubility or compatibility data when established compounding formulas are not available

94
New cards

what can unpublished data show tell us?

internal studies/validation

95
New cards

liquid dosage forms

encompasses many formulations such as: suspensions, solutions (syrups, tinctures, elixirs, spirits, oral, otic, ophthalmic, nasal), emulsions (oil-in-water, water-in-oil)

96
New cards

T/F: liquid dosage forms should be calculated and compounded only for the prescribed quantity (no extras)

True!

97
New cards

advantages of oral liquid dosage forms

can accommodate precise, nonstandard dosing; easy to administer (oral admin, enteral feeding tubes)

98
New cards

disadvantages of oral liquid dosage forms

drug often less stable in liquid form; shorter BUD; difficult to mask unpleasant smells or tastes; specific storage conditions; safety (measuring devices, measuring abilities, variability in standard concentrations)

99
New cards

Safety issues with suspensions

Many medications may have compounding formulas available for multiple different final concentrations; important when compounding medications to ensure patient is getting the intended concentration (and dose) especially at transitions of car, changing pharmacies, and changing prescribers

100
New cards

what is ASHP Standardize4Safety

a national, interprofessional effort to standardize medication concentrations to reduced errors, especially during transitions of care - includes standard concentrations for IV infusions, compounded oral liquid medications, IV intermittent medications, PCAs, and epidurals